Antiverse Raises $9.3M Series A To Advance AI Antibody Platform
Kailee Rainse / startuprise - UK-based Antiverse, a biotech startup developing AI-designed therapeutic antibodies for hard-to-target disease proteins, has raised $9.3 million in a Series A round led by Soulmates Ventures, with participation from Innovation Investment Capital, DOMiNO V…
Back to Top / Tuesday, March 3, 2026, 8:22 am / permalink 20054 / 5 stories in 3 days
Outpost Bio raises $3.5M pre-seed for human microbiology models
Tamara Djurickovic / tech - Outpost Bio, a companyfocused on decoding complex interactions in human biology, has raised a $3.5million pre-seed round co-led by Merantix Capital and Seedcamp, withparticipation from OpenSeed VC, De...
Back to Top / Monday, March 2, 2026, 2:20 am / permalink 19971 / 5 stories in 5 days
Arcellx (ACLX) Stock Jumps 78% as Gilead Agrees to $7.8B Acquisition
Trader Edge / parameter - TLDR Gilead Sciences is acquiring Arcellx for $7.8 billion, paying $115 per share in cash plus a $5 contingent value right Arcellx stock jumped over 78% in premarket trading Monday following the announcement The deal centers on anito-cel, a CAR-T cell the…
Back to Top / Monday, February 23, 2026, 9:21 am / permalink 19567 / 3 stories in 11 days
Bedfordshire biotech Tozaro secures £6M from Mercia to scale gene therapy platform
Vignesh R / techfundingnews - Modern medicine is facing a significant pricing crisis. While breakthrough gene therapies offer potential cures for rare genetic…
Back to Top / Monday, February 16, 2026, 8:21 am / permalink 19242 / 4 stories in 18 days
UK healthtech startup Nul raises $1M to support alcohol reduction efforts
Tamara Djurickovic / tech - Nul, a UK-basedhealthtech startup developing a supported alcohol reduction platform thatcombines clinical care and prescription medication, has raised $1 million inseed funding. The round was led by d...
Back to Top / Monday, February 16, 2026, 4:20 am / permalink 19234 / 3 stories in 18 days
Amazon Pharmacy to expand same-day delivery to nearly 4,500 US cities
Aisha Malik / techcrunch - The expansion will cover customers in newly served states such as Idaho and Massachusetts.
Back to Top / Wednesday, February 11, 2026, 2:20 pm / permalink 19034 / 6 stories in 23 days
Eli Lilly (LLY) Stock Acquires Orna Therapeutics for Up to $2.4 Billion
Trader Edge / parameter - TLDR Eli Lilly (LLY) announced a deal to buy Orna Therapeutics for up to $2.4 billion in cash to expand its cell therapy capabilities. Orna’s lead asset ORN-252 uses circular RNA technology to create CAR-T therapies inside patients’ bodies for autoimmune …
Back to Top / Monday, February 9, 2026, 11:22 am / permalink 18943 / 3 stories in 25 days
Biorce raises $52M to support global rollout of its AI clinical trial platform
Tamara Djurickovic / tech - Barcelona-basedBiorce, a health AI company focused on clinical trial design and execution, hasclosed a $52 million Series A round. The financing includes new investment fromDST Global Partners, with e...
Back to Top / Monday, February 2, 2026, 1:20 am / permalink 18649 / 5 stories in 4 wks
Nuclera Raises $87M Series C To Advance Antibody Research
Kailee Rainse / startuprise - Biotech firm Nuclera has raised an additional $12 million increasing its total Series C funding to $87 million. The extension round was led by Elevage Medical Technologies and Jonathan Milner with participation from existing investors including British Bu…
Back to Top / Tuesday, January 13, 2026, 6:21 am / permalink 17824 / 5 stories in 7 wks
Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly
Ian KingMadison Muller / bloomberg - Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.
Back to Top / Monday, January 12, 2026, 4:21 pm / permalink 17797 / 6 stories in 7 wks
FluoSphera zips CHF 1.15M seed for 3D human organ models that cut drug failures
Vignesh R / techfundingnews - Developing new medicines is a long and costly process, taking 10 to 15 years and billions of dollars.…
Back to Top / Monday, January 12, 2026, 3:20 am / permalink 17770 / 6 stories in 7 wks
If you’re over 65 and can still do these 8 things without reminders, your cognitive health is remarkable
Sarah Mitchell / siliconcanals - While most people over 65 rely on countless reminders and notes to get through their day, those who can effortlessly manage these eight specific daily tasks are demonstrating cognitive abilities that neuroscientists consider extraordinary for their age.
- Anthropic vies with OpenAI in healthcare chatbot race. (3)
- Anthropic’s Claude expands with HIPAA-ready features. (7)
- Other health AI developments and unrelated aging insights. (2)
- All Other Stories
Anthropic vies with OpenAI in healthcare chatbot race.
Anthropic’s Claude expands with HIPAA-ready features.
Other health AI developments and unrelated aging insights.
All Other Stories
Back to Top / Sunday, January 11, 2026, 8:20 pm / permalink 17760 / 13 stories in 7 wks
Amgen acquires Oxford-based Dark Blue in deal worth up to €718 million to advance leukemia programme
David Cendon Garcia / eu-startups - Dark Blue Therapeutics, a British discovery and development BioTech company innovating the next generation of precision oncology medicines, has been acquired by US-based global BioTech company Amgen, in a transaction valued at up to €718 million ($840 mil…
Back to Top / Wednesday, January 7, 2026, 9:21 am / permalink 17591 / 5 stories in 1 month
CDC panel overturns 1991 newborn vaccine policy, triggering warnings of a public health backslide
Taylor Hatmaker / fastcompany - A powerful advisory group within the CDC voted Friday to overturn a longstanding precaution designed to protect newborn babies.If the change is approved by the acting director of the agency, the government will no longer universally recommend the hepatiti…
Back to Top / Friday, December 5, 2025, 4:21 pm / permalink 16626 / 7 stories in 3 months
Sofinnova Partners Raises €650M To Support Biopharma And MedTech Innovation
Kailee Rainse / startuprise - Life sciences venture capital firm Sofinnova Partners has closed its latest flagship fund, Sofinnova Capital XI, at €650 million ($750 million), significantly surpassing its original fundraising target. Based in Paris, London, and Milan, Sofinnova Capital…
Back to Top / Monday, November 17, 2025, 1:20 am / permalink 16015 / 4 stories in 3 months
Adaptam Therapeutics raises €3M to target tumour immune evasion
Abhinaya Prabhu / techfundingnews - Spanish biotech startup Adaptam Therapeutics has raised €3 million in a pre-seed financing round led by Criteria Bio…
Back to Top / Monday, October 27, 2025, 8:23 am / permalink 15444 / 4 stories in 4 months
Sweden’s Lithea Raises €851k To Develop Targeted Therapy For Childhood Bone Cancer
Kailee Rainse / startuprise - Lund-based Lithea, a biotech company developing targeted cancer treatments that deliver drugs directly into tumours, has raised €851,000 from existing investors to advance its drug delivery system and prepare its lead candidate, LIT1001, for clinical tria…
Back to Top / Monday, October 27, 2025, 6:20 am / permalink 15437 / 2 stories in 4 months
Swedish biotech Cellcolabs raises $12M to make stem cell therapies mainstream
Sofia Chesnokova / techfundingnews - The global demand for regenerative therapies is reaching new heights, but researchers and patients alike continue to face…
Back to Top / Monday, October 27, 2025, 4:20 am / permalink 15434 / 5 stories in 4 months
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Dylan Tokar / wsj - The Swiss pharmaceutical company says the purchase would complement its existing pipeline of treatments for neuromuscle disorders.
Back to Top / Sunday, October 26, 2025, 5:20 pm / permalink 15427 / 2 stories in 4 months
Claude enters the lab: Anthropic bets big on life sciences - Financial Times
google - Claude enters the lab: Anthropic bets big on life sciences Financial Times
Back to Top / Monday, October 20, 2025, 1:20 pm / permalink 15226 / 4 stories in 4 months